Appendix 4D and Half Yearly Accounts
Cleo Diagnostics (COV:AU) has announced Appendix 4D and Half Yearly Accounts Download the PDF here. This post appeared first on investingnews.com
Argo Launches Digital Gold Investment Platform in the US, Aims to Disrupt Industry
Argo Digital US has launched its 24/7 gold investment platform in the US. In an early February announcement, the Sprott family-backed company said the launch reflects its commitment to delivering…
Chief Justice John Roberts pauses judge’s order for Trump admin to pay foreign aid contractors by midnight
U.S. Supreme Court Justice John Roberts on Wednesday paused a federal judge’s order that required the Trump administration to pay around $2 billion in foreign aid funds to contractors by…
Is Now a Good Time to Buy Bitcoin?
Bitcoin is prone to price volatility, with wide swings to the upside and downside. There has been renewed interest in cryptocurrencies following the election of US President Donald Trump. The…
Red Cross receives bodies of 4 slain hostages during Israel-Hamas exchange
Hamas released four dead hostages to the Red Cross on Thursday, marking another step in the first phase of the cease-fire between the terrorist group and Israel. The exchange, which…
NVIDIA Earnings: What Investors Need to Know
NVIDIA’s (NASDAQ:NVDA) results have once again exceeded analysts’ expectations. Despite bearish sentiment leading up to the release of its earnings, the company delivered strong results for its fourth fiscal quarter…
Crypto Market Recap: Bybit Investigates Lazarus Hack, SEC Ends Uniswap Investigation
Here’s a quick recap of the crypto landscape for Wednesday (February 26) as of 9:00 p.m. UTC. Bitcoin and Ethereum price update Bitcoin (BTC) is currently trading at US$84,419.28, reflecting…
Drilling Commences at Penny South Gold Project, Western Australia
Strata Minerals Limited (ASX: SMX, “Strata” or “the Company”) is pleased to announce commencement of a maiden drill program at its Penny South Gold Project in Western Australia. Highlights: Maiden…
Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), today announced that it has completed its trial entitled “A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple…
Sarama Resources Advances Mt Venn Gold Project Acquisition
Sarama Resources Ltd. (“Sarama” or the “Company”) (ASX:SRR, TSX- V:SWA) is pleased to advise that it has reached binding agreement (the “Agreement”) with Orbminco Limited (“Orbminco”) (ASX: OB1), an arm’s…